{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T08:27:14Z","timestamp":1790324834779,"version":"4.1.0"},"reference-count":152,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,7,24]],"date-time":"2018-07-24T00:00:00Z","timestamp":1532390400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"DOI":"10.3389\/fneur.2018.00551","type":"journal-article","created":{"date-parts":[[2018,7,24]],"date-time":"2018-07-24T04:16:19Z","timestamp":1532405779000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":46,"title":["Restless Legs Syndrome and Parkinson Disease: A Causal Relationship Between the Two Disorders?"],"prefix":"10.3389","volume":"9","author":[{"given":"Luigi","family":"Ferini-Strambi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Carli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Casoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Galbiati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,7,24]]},"reference":[{"key":"B1","volume-title":"International Classification of Sleep Disorders","year":"2014"},{"key":"B2","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/j.sleep.2014.03.025","article-title":"International Restless Legs Syndrome Study Group","volume":"15","author":"Allen","year":"2014","journal-title":"Sleep Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.ijpsycho.2014.12.005","article-title":"Neurocognitive function in patients with idiopathic restless legs syndrome before and after treatment with dopamine-agonist","volume":"95","author":"Galbiati","year":"2015","journal-title":"Int J Psychophysiol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1159\/000228261","article-title":"Excessive Daytime sleepiness in idiopathic restless legs syndrome: characteristics and evolution under dopaminergic treatment","volume":"62","author":"Kallweit","year":"2009","journal-title":"Eur Neurol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.5665\/sleep.3934","article-title":"Increased electroencephalographic high frequencies during the sleep onset period in patients with restless legs syndrome","volume":"37","author":"Ferri","year":"2014","journal-title":"Sleep"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.smrv.2011.05.002","article-title":"Epidemiology of restless legs syndrome: a synthesis of the literature","author":"Ohayon","year":"2012","journal-title":"Sleep Med Rev."},{"key":"B7","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.jsmc.2015.05.004","article-title":"Restless leg syndrome across the globe: epidemiology of the restless legs syndrome\/Willis-Ekbom disease","volume":"10","author":"Koo","year":"2015","journal-title":"Sleep Med Clin"},{"key":"B8","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s11940-015-0390-1","volume":"18","author":"Rinaldi","year":"2016","journal-title":"Curr Treat Options Neurol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.sleep.2016.01.017","article-title":"Guidelines for the first-line treatment of restless legs syndrome\/Willis-Ekbom disease, prevention and treatment of dopaminergic augmentation: a combined task force of the IRLSSG, EURLSSG, and the RLS-foundation","volume":"21","author":"Garcia-Borreguero","year":"2016","journal-title":"Sleep Med"},{"key":"B10","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1016\/S1474-4422(17)30327-7","article-title":"Identification of novel risk loci for restless legs syndrome in genome-wide association studies in individuals of European ancestry: a meta-analysis","volume":"16","author":"Schormair","year":"2017","journal-title":"Lancet Neurol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1212\/01.wnl.0000336341.72621.db","article-title":"Is there a higher risk of restless legs syndrome in peripheral neuropathy?","volume":"72","author":"Hattan","year":"2009","journal-title":"Neurology"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1016\/j.sleep.2014.05.009","article-title":"Altered brain iron homeostasis and dopaminergic function in restless legs syndrome (Willis-Ekbom disease)","volume":"15","author":"Earley","year":"2014","journal-title":"Sleep Med"},{"key":"B13","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1177\/1352458506074644","article-title":"Prevalence of restless legs syndrome and REM sleep behavior disorder in multiple sclerosis","volume":"13","author":"Gomez-Choco","year":"2007","journal-title":"Mult Scler"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1007\/s00415-013-7065-1","article-title":"The relationship among restless legs syndrome (Willis-Ekbom disease), hypertension, cardiovascular disease, and cerebrovascular disease","volume":"261","author":"Ferini-Strambi","year":"2014","journal-title":"J Neurol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.sleep.2004.01.016","article-title":"Parkinson's disease and RLS: the dopaminergic bridge","volume":"5","author":"Rye","year":"2004","journal-title":"Sleep Med"},{"key":"B16","first-page":"175","article-title":"The low prevalence of primary restless legs syndrome in Thai Parkinson's disease patients at Chulalongkorn University Hospital","volume":"95","author":"Jagota","year":"2012","journal-title":"J Med Assoc Thai"},{"key":"B17","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1001\/archneur.59.3.421","article-title":"Exploring the relationship between Parkinson disease and restless legs syndrome","volume":"3","author":"Ondo","year":"2002","journal-title":"Arch Neurol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1002\/mds.870100517","article-title":"Toward a better definition of the restless legs syndrome","volume":"10","author":"Walters","year":"1995","journal-title":"Mov Disord"},{"key":"B19","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1002\/mds.10167","article-title":"Sleep disorders in Parkinson's disease","volume":"4","author":"Kumar","year":"2002","journal-title":"Mov Disord."},{"key":"B20","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/S0022-510X(02)00020-5","article-title":"Wong Restless legs syndrome in Parkinson's disease","volume":"196","author":"Tan","year":"2002","journal-title":"J Neurol Sci."},{"key":"B21","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1002\/mds.10307","article-title":"Restless legs syndrome in Parkinson's disease: a case-controlled study","volume":"18","author":"Krishnan","year":"2003","journal-title":"Mov Disord"},{"key":"B22","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/S1389-9457(03)00010-8","article-title":"Restless legs syndrome diagnosis and epidemiology workshop at the national institutes of health; international restless legs syndrome study group","volume":"4","author":"Allen","year":"2003","journal-title":"Sleep Med"},{"key":"B23","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.jns.2003.08.010","article-title":"Snoring and excessive daytime sleepiness in Parkinson's disease","volume":"217","author":"Braga-Neto","year":"2004","journal-title":"J Neurol Sci."},{"key":"B24","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1002\/mds.20734","article-title":"Prevalence and clinical characteristics of restless legs syndrome in japanese patients with Parkinson's Disease","volume":"21","author":"Nomura","year":"2006","journal-title":"Mov Disord"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1002\/mds.21624","article-title":"Restless legs syndrome in Parkinson's disease","volume":"22","author":"G\u00f3mez-Esteban","year":"2007","journal-title":"Mov Disord."},{"key":"B26","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.jns.2007.09.033","article-title":"Case-control study of restless legs syndrome and quality of sleep in Parkinson's disease","volume":"266","author":"Loo","year":"2008","journal-title":"J Neurol Sci."},{"key":"B27","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s10072-009-0037-7","article-title":"Absence of co-morbidity of Parkinson disease and restless legs syndrome: a case-control study in patients attending a movement disorders clinic","volume":"30","author":"Calzetti","year":"2009","journal-title":"Neurol Sci."},{"key":"B28","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1002\/mds.22410","article-title":"Factors contributing to the development of restless legs syndrome in patients with Parkinson disease","volume":"24","author":"Lee","year":"2009","journal-title":"Mov Disord"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.1002\/mds.22711","article-title":"Restless legs syndrome, rapid eye movement sleep behavior disorder, and hypersomnia in patients with two parkin mutations","volume":"24","author":"Limousin","year":"2009","journal-title":"Mov Disord"},{"key":"B30","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.1002\/mds.22694","article-title":"Restless legs syndrome in Parkinson's Disease","volume":"14","author":"Peralta","year":"2009","journal-title":"Mov Disord."},{"key":"B31","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.parkreldis.2010.01.002","article-title":"Sleep disturbances and brain MRI morphometry in Parkinson's disease, multiple system atrophy and progressive supranuclear palsy - a comparative study","volume":"16","author":"Gama","year":"2010","journal-title":"Parkinsonism Relat Disord"},{"key":"B32","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1590\/S0004-282X2010000600007","article-title":"Restless legs syndrome in Parkinson's disease: clinical characteristics and biochemical correlations","volume":"68","author":"Guerreiro","year":"2010","journal-title":"Arq Neuropsiquiatr"},{"key":"B33","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.jns.2008.12.022","article-title":"Does the endogenous opiate system play a role in the restless legs syndrome? A pilot post-mortem study","volume":"279","author":"Walters","year":"2009","journal-title":"J Neurol Sci"},{"key":"B34","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.1002\/mds.23241","article-title":"Prevalence and clinical profile of restless legs syndrome in Parkinson's Disease","volume":"25","author":"Verbaan","year":"2010","journal-title":"Mov Disord"},{"key":"B35","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.jns.2011.08.012","article-title":"A study of the prevalence of restless legs syndrome in previously untreated Parkinson's disease patients: absence of co-morbid association","volume":"310","author":"Angelini","year":"2011","journal-title":"J Neurol Sci"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1212\/WNL.0b013e31823a0cc8","article-title":"Increased risk of leg motor restlessness but not RLS in early Parkinson disease","volume":"77","author":"Gjerstad","year":"2011","journal-title":"Neurology"},{"key":"B37","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.jns.2012.03.022","article-title":"Nocturnal disturbances and restlessness in Parkinson's disease: using the Japanese version of the Parkinson's disease sleep scale-2","volume":"318","author":"Suzuki","year":"2012","journal-title":"J Neurol Sci"},{"key":"B38","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/1471-2377-12-71","article-title":"Sleep problems in Parkinson's disease: a community-based study in Norway","volume":"12","author":"Svensson","year":"2012","journal-title":"BMC Neurol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"535613","DOI":"10.1155\/2013\/535613","article-title":"Restless legs syndrome and its associated risk factors in Parkinson's disease","volume":"2013","author":"Azmin","year":"2013","journal-title":"Parkinsons Dis."},{"key":"B40","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.parkreldis.2012.12.005","article-title":"Prevalence and profile of restless legs syndrome in Parkinson's disease and other neurodegenerative disorders: a case-control study","volume":"19","author":"Bhalsing","year":"2013","journal-title":"Parkinsonism Relat Disord"},{"key":"B41","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.jns.2013.01.039","article-title":"Association of pain, Parkinson's disease, and restless legs syndrome","volume":"327","author":"Rana","year":"2013","journal-title":"J Neurol Sci."},{"key":"B42","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1111\/ane.12011","article-title":"No association between neuropathy and restless legs in Parkinson's disease","volume":"127","author":"Rajabally","year":"2013","journal-title":"Acta Neurol Scand."},{"key":"B43","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.parkreldis.2012.09.009","article-title":"Restless legs syndrome in Korean patients with drug-na\u00efve Parkinson's disease: a nation-wide study","volume":"19","author":"Shin","year":"2013","journal-title":"Parkinsonism Relat Disord."},{"key":"B44","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.jns.2014.06.056","article-title":"Association between nocturnal\/supine hypertension and restless legs syndrome in patients with Parkinson's disease","volume":"344","author":"Oh","year":"2014","journal-title":"J Neurol Sci"},{"key":"B45","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1111\/ane.12307","article-title":"Restless legs syndrome in patients with Parkinson's disease: a comparative study on prevalence, clinical characteristics, quality of life and nutritional status","volume":"131","author":"Fereshtehnejad","year":"2015","journal-title":"Acta Neurol Scand"},{"key":"B46","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1159\/000375493","article-title":"Parkinson's disease and restless legs syndrome","volume":"73","author":"Ylikoski","year":"2015","journal-title":"Eur Neurol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.jns.2015.07.008","article-title":"Clinical characteristics of leg restlessness in Parkinson's disease compared with idiopathic Restless Legs Syndrome","volume":"357","author":"Zhu","year":"2015","journal-title":"J Neurol Sci"},{"key":"B48","doi-asserted-by":"publisher","first-page":"116","DOI":"10.3109\/00207454.2014.994208","article-title":"Association of restless legs syndrome, pain, and mood disorders in Parkinson's disease","volume":"126","author":"Rana","year":"2016","journal-title":"Int J Neurosci"},{"key":"B49","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1159\/000481939","article-title":"High frequency of sleep disorders in parkinson's disease and its relationship with quality of life","volume":"78","author":"Sobreira-Neto","year":"2017","journal-title":"Eur Neurol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.parkreldis.2017.08.007","article-title":"Characterizing restless legs syndrome and leg motor restlessness in patients with Parkinson's disease: a multicenter case-controlled study","volume":"44","author":"Suzuki","year":"2017","journal-title":"Parkinsonism Relat Disord."},{"key":"B51","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1212\/01.wnl.0000223316.53428.c9","article-title":"Restless legs syndrome: revisiting the dopamine hypothesis from the spinal cord perspective","volume":"67","author":"Clemens","year":"2006","journal-title":"Neurology"},{"key":"B52","doi-asserted-by":"publisher","first-page":"S466","DOI":"10.1002\/mds.21545","article-title":"State of the art in restless legs syndrome therapy: practice recommendations for treating restless legs syndrome","volume":"22","author":"Oertel","year":"2007","journal-title":"Mov Disord."},{"key":"B53","doi-asserted-by":"publisher","first-page":"2654","DOI":"10.1002\/mds.23256","article-title":"Restless legs syndrome and Parkinson's disease in men","volume":"25","author":"Gao","year":"2010","journal-title":"Mov Disord"},{"key":"B54","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1046\/j.0962-1105.2003.00368.x","article-title":"A preliminary look at the percentage of patients with restless legs syndrome who also have parkinson disease, essential tremor or tourette syndrome in a single practice","volume":"12","author":"Walters","year":"2003","journal-title":"J Sleep Res"},{"key":"B55","doi-asserted-by":"publisher","first-page":"526","DOI":"10.3109\/00207454.2014.987771","article-title":"Does idiopathic restless legs syndrome delay onset and reduce severity of Parkinson's disease: a pilot study","volume":"125","author":"Dragan","year":"2015","journal-title":"Int J Neurosci"},{"key":"B56","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1212\/WNL.54.5.1064","article-title":"Prevalence and risk factors of RLS in an elderly population: the MEMO study","volume":"54","author":"Rothdach","year":"2000","journal-title":"Neurology"},{"key":"B57","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1001\/archinte.164.2.196","article-title":"Sex and the risk of restless legs syndrome in the general population","volume":"164","author":"Berger","year":"2004","journal-title":"Arch Intern Med"},{"key":"B58","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.sleep.2004.03.006","article-title":"Impact, diagnosis and treatment of restless legs syndrome (RLS) in a primary care population: the REST (RLS epidemiology, symptoms, and treatment) primary care study","volume":"5","author":"Hening","year":"2004","journal-title":"Sleep Med"},{"key":"B59","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1001\/archinte.165.11.1286","article-title":"Restless legs syndrome prevalence and impact: REST general population study","volume":"165","author":"Allen","year":"2005","journal-title":"Arch Intern Med."},{"key":"B60","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1378\/chest.129.1.76","article-title":"Prevalence and correlates of restless legs syndrome: results from the 2005 National Sleep Foundation Poll","volume":"129","author":"Phillips","year":"2006","journal-title":"Chest"},{"key":"B61","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/0361-9230(93)90259-E","article-title":"Dorsal and ventral dopaminergic innervation of the spinal cord: functional implications","volume":"30","author":"Weil-Fugazza","year":"1993","journal-title":"Brain Res Bull"},{"key":"B62","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1001\/archneurol.2008.561","article-title":"Overview of the extranigral aspects of Parkinson disease","volume":"66","author":"Lim","year":"2009","journal-title":"Arch Neurol."},{"key":"B63","first-page":"309","article-title":"Brain iron and dopamine receptor function","volume":"37","author":"Youdim","year":"1983","journal-title":"Adv Biochem Psychopharmacol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/s00702-013-1132-8","article-title":"A long-term prospective follow-up study of incident RLS in the course of chronic DAergic therapy in newly diagnosed untreated patients with Parkinson's disease","volume":"121","author":"Calzetti","year":"2014","journal-title":"J Neural Transm."},{"key":"B65","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s00415-015-7937-7","article-title":"A prospective study of the cumulative incidence and course of restless legs syndrome in de novo patients with Parkinson's disease during chronic dopaminergic therapy","volume":"263","author":"Marchesi","year":"2016","journal-title":"J Neurol"},{"key":"B66","doi-asserted-by":"publisher","first-page":"405","DOI":"10.5665\/sleep.5452","article-title":"A Four-year longitudinal study on restless legs syndrome in Parkinson Disease","volume":"39","author":"Moccia","year":"2016","journal-title":"Sleep"},{"key":"B67","doi-asserted-by":"publisher","first-page":"369","DOI":"10.5665\/sleep.3416","article-title":"Restless legs syndrome: an early clinical feature of Parkinson disease in men","volume":"37","author":"Wong","year":"2014","journal-title":"Sleep"},{"key":"B68","doi-asserted-by":"publisher","first-page":"zsw065","DOI":"10.1093\/sleep\/zsw065","article-title":"Association of Restless Legs Syndrome With Incident Parkinson's Disease","volume":"40","author":"Szatmari","year":"2017","journal-title":"Sleep"},{"key":"B69","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/j.neuron.2010.11.022","article-title":"Dopamine in motivational control: rewarding, aversive, and alerting","volume":"68","author":"Bromberg-Martin","year":"2010","journal-title":"Neuron"},{"key":"B70","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1162\/jocn_a_00503","article-title":"Dopamine function and the efficiency of human movement","volume":"26","author":"Gepshtein","year":"2014","journal-title":"J Cogn Neurosci"},{"key":"B71","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.smrv.2014.10.006","article-title":"Catechol-O-methyltransferase, dopamine, and sleep-wake regulation","volume":"22","author":"Dauvilliers","year":"2015","journal-title":"Sleep Med Rev."},{"key":"B72","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.neures.2017.04.008","article-title":"The control of sleep and wakefulness by mesolimbic dopamine systems","volume":"118","author":"Oishi","year":"2017","journal-title":"Neurosci Res."},{"key":"B73","doi-asserted-by":"publisher","first-page":"380","DOI":"10.2174\/1871527316666170320145429","article-title":"Dopaminergic modulation of sleep-wake states","volume":"16","author":"Herrera-Solis","year":"2017","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"B74","volume-title":"Goodman and Gilman's the Pharmacological Basis of Therapeutics.","author":"Hardman","year":"2001"},{"key":"B75","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S0022-3565(24)37050-8","article-title":"Modafinil induces wakefulness without intensifying motor activity or subsequent rebound hypersomnolence in the rat","volume":"283","author":"Edgar","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"B76","first-page":"49","article-title":"Increased dopaminergic transmission mediates the wake-promoting effects of CNS stimulants","volume":"1","author":"Nishino","year":"1998","journal-title":"Sleep Res Online"},{"key":"B77","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1097\/00002826-199901000-00004","article-title":"L-dopa induced sedation: a double-blind cross-over controlled study versus triazolam and placebo in healthy volunteers","volume":"22","author":"Andreau","year":"1999","journal-title":"Clin Neuropharmacol"},{"key":"B78","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1212\/WNL.58.3.460","article-title":"Effect of ropinirole on sleep onset: a randomized placebo-controlled study in healthy volunteers","volume":"58","author":"Ferreira","year":"2002","journal-title":"Neurology"},{"key":"B79","first-page":"121","article-title":"Dopamine agonists and sleep in man","volume-title":"Sleep: Neurotransmitters and Neuromodulators.","author":"Cianchetti","year":"1989"},{"key":"B80","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/0014-2999(93)90823-Z","article-title":"The dopamine D1 receptor agonists, A68930 and SKF 38393, induce arousal and suppress REM sleep in the rat","volume":"235","author":"Trampus","year":"1993","journal-title":"Eur J Pharmacol."},{"key":"B81","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/S0022-3565(25)38367-9","article-title":"Differential effects of dopamine D1 and D2 receptor antagonist antipsychotics on sleep\u2013wake patterns in the rat","volume":"266","author":"Ongini","year":"1993","journal-title":"J Pharmacol Exp Ther."},{"key":"B82","doi-asserted-by":"publisher","first-page":"9541","DOI":"10.1523\/JNEUROSCI.2891-04.2004","article-title":"Dopamine modulates release from corticostriatal terminals","volume":"24","author":"Bamford","year":"2004","journal-title":"J Neurosci"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1016\/S1471-1931(00)00019-7","article-title":"Molecular effects of dopamine on striatal-projection pathways","author":"Gerfen","year":"2000","journal-title":"Trends Neurosci.S"},{"key":"B84","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1002\/mds.870130506","article-title":"Dopamine D3 receptor is decreased and D2 receptor is elevated in the striatum of Parkinson's disease","volume":"13","author":"Ryoo","year":"1998","journal-title":"Mov Disord."},{"key":"B85","doi-asserted-by":"publisher","first-page":"65","DOI":"10.3389\/fnagi.2016.00065","article-title":"Degeneration of dopaminergic neurons due to metabolic alterations and Parkinson's Disease","volume":"8","author":"Song","year":"2016","journal-title":"Front Aging Neurosci"},{"key":"B86","doi-asserted-by":"publisher","first-page":"j104","DOI":"10.1136\/bmj.j104","article-title":"New concepts in the management of restless legs Syndrome","volume":"356","author":"Garcia-Borreguero","year":"2017","journal-title":"BMJ"},{"key":"B87","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/S0091-3057(01)00563-9","article-title":"Iron deficiency decreases dopamine D1 and D2 receptors in rat brain","volume":"69","author":"Erikson","year":"2001","journal-title":"Pharmacol Biochem Behav"},{"key":"B88","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.jns.2004.02.004","article-title":"Thy1 expression in the brain is affected by iron and is decreased in Restless Legs Syndrome","volume":"220","author":"Wang","year":"2004","journal-title":"J Neurol Sci."},{"key":"B89","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1002\/1531-8257(200101)16:1<144::AID-MDS1009>3.0.CO;2-F","article-title":"CSF dopamine, serotonin, and biopterin metabolites in patients with restless legs syndrome","volume":"16","author":"Earley","year":"2001","journal-title":"Mov Disord"},{"key":"B90","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1002\/mds.10631","article-title":"Normal dopaminergic and serotonergic metabolites in cerebrospinal fluid and blood of restless legs syndrome patients","volume":"19","author":"Stiasny-Kolster","year":"2004","journal-title":"Mov Disord"},{"key":"B91","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.sleep.2005.09.006","article-title":"Circadian changes in CSF dopaminergic measures in restless legs syndrome","volume":"7","author":"Earley","year":"2006","journal-title":"Sleep Med"},{"key":"B92","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.1093\/brain\/awp125","article-title":"Altered dopaminergic profile in the putamen and substantia nigra in restless leg syndrome","volume":"132","author":"Connor","year":"2009","journal-title":"Brain"},{"key":"B93","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.sleep.2007.11.012","article-title":"Abnormally increased CSF 3-ortho-methyldopa (3-OMD) in untreated restless legs syndrome (RLS) patients indicates more severe disease and possibly abnormally increased dopamine synthesis","volume":"10","author":"Allen","year":"2009","journal-title":"Sleep Med"},{"key":"B94","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1007\/s00415-017-8431-1","article-title":"Iron, dopamine, genetics, and hormones in the pathophysiology of restless legs syndrome","volume":"264","author":"Khan","year":"2017","journal-title":"J Neurol."},{"key":"B95","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.jsmc.2015.05.022","article-title":"Restless Leg Syndrome\/willis-ekbom disease pathophysiology","volume":"10","author":"Allen","year":"2015","journal-title":"Sleep Med Clin"},{"key":"B96","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1093\/sleep\/28.9.1069","article-title":"Ferritin levels in the cerebrospinal fluid and restless legs syndrome: effects of different clinical phenotypes","volume":"28","author":"Earley","year":"2005","journal-title":"Sleep"},{"key":"B97","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1111\/j.1365-2869.2004.00403.x","article-title":"CSF iron, ferritin and transferrin levels in restless legs syndrome","volume":"14","author":"Mizuno","year":"2005","journal-title":"J Sleep Res"},{"key":"B98","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1002\/ana.20572","article-title":"Transcranial ultrasound shows nigral hypoechogenicity in restless legs syndrome","volume":"58","author":"Schmidauer","year":"2005","journal-title":"Ann Neurol"},{"key":"B99","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.lab.2005.06.011","article-title":"Ferritin subunits in CSF are decreased in restless legs syndrome","volume":"147","author":"Clardy","year":"2006","journal-title":"J Lab Clin Med."},{"key":"B100","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1212\/01.WNL.0000123251.60485.AC","article-title":"Decreased transferrin receptor expression by neuromelanin cells in restless legs syndrome","volume":"62","author":"Connor","year":"2004","journal-title":"Neurology"},{"key":"B101","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.sleep.2016.07.018","article-title":"Brain imaging and networks in restless legs syndrome","volume":"31","author":"Rizzo","year":"2017","journal-title":"Sleep Med"},{"key":"B102","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/BF01271478","article-title":"Single photon emission tomography (SPET) imaging of dopamine D2-receptors in the course of dopamine replacement therapy in patients with nocturnal myoclonus syndrome (NMS)","volume":"99","author":"Staedt","year":"1995","journal-title":"J Neural Transm."},{"key":"B103","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1212\/WNL.54.2.502","article-title":"An FDOPA PET study in patients with periodic limb movement disorder and restless legs syndrome","volume":"54","author":"Ruottinen","year":"2000","journal-title":"Neurology"},{"key":"B104","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1007\/PL00007859","article-title":"SPECT imaging of striatal pre and postsynaptic dopaminergic status in restless legs syndrome with periodic leg movements in sleep","volume":"249","author":"Michaud","year":"2002","journal-title":"J Neurol"},{"key":"B105","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1093\/sleep\/34.3.341","article-title":"The dopamine transporter is decreased in the striatum of subjects with restless legs syndrome","volume":"34","author":"Earley","year":"2011","journal-title":"Sleep"},{"key":"B106","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1111\/j.1468-1331.2012.03705.x","article-title":"Increased striatal dopamine transporter density in moderately severe old restless legs syndrome patients","volume":"19","author":"Kim","year":"2012","journal-title":"Eur J Neurol"},{"key":"B107","doi-asserted-by":"publisher","first-page":"e14","DOI":"10.1097\/RLU.0000000000000916","article-title":"99mTc-TRODAT-1 SPECT as a potential neuroimaging biomarker in patients with restless legs syndrome","volume":"41","author":"Lin","year":"2016","journal-title":"Clin Nucl Med"},{"key":"B108","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1038\/jcbfm.2011.201","article-title":"In vivo mesolimbic D2\/3 receptor binding predicts post therapeutic clinical responses in restless legs syndrome: a positron emission tomography study","volume":"32","author":"Oboshi","year":"2012","journal-title":"J Cereb Blood Flow Metab."},{"key":"B109","doi-asserted-by":"publisher","first-page":"51","DOI":"10.5665\/sleep.2300","article-title":"Increased synaptic dopamine in the putamen in restless legs syndrome","volume":"36","author":"Earley","year":"2013","journal-title":"Sleep"},{"key":"B110","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1212\/WNL.56.2.263","article-title":"MRI measurement of brain iron in patients with restless legs syndrome","volume":"56","author":"Allen","year":"2001","journal-title":"Neurology"},{"key":"B111","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.sleep.2005.11.009","article-title":"MRI-determined regional brain iron concentrations in early- and late-onset restless legs syndrome","volume":"7","author":"Earley","year":"2006","journal-title":"Sleep Med"},{"key":"B112","doi-asserted-by":"publisher","first-page":"667","DOI":"10.3174\/ajnr.A2829","article-title":"Investigation of unmedicated early onset restless legs syndrome by voxel-based morphometry, T2 relaxometry, and functional MR imaging during the night-time hours","volume":"33","author":"Margariti","year":"2012","journal-title":"AJNR Am J Neuroradiol"},{"key":"B113","doi-asserted-by":"publisher","first-page":"197","DOI":"10.3988\/jcn.2014.10.3.197","article-title":"T2 relaxometry using 3","volume":"10","author":"Moon","year":"2014","journal-title":"J Clin Neurol"},{"key":"B114","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1002\/mds.22070","article-title":"Multiregional brain iron deficiency in restless legs syndrome","volume":"23","author":"Godau","year":"2008","journal-title":"Mov Disord."},{"key":"B115","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.1002\/mds.25576","article-title":"Low brain iron content in idiopathic Restless Legs Syndrome patients detected by phase imaging","volume":"28","author":"Rizzo","year":"2013","journal-title":"Mov Disord"},{"key":"B116","doi-asserted-by":"publisher","first-page":"341","DOI":"10.2147\/MDER.S83629","article-title":"A comparison of MRI tissue relaxometry and ROI methods used to determine regional brain iron concentrations in restless legs syndrome","volume":"8","author":"Moon","year":"2015","journal-title":"Med Devices"},{"key":"B117","doi-asserted-by":"publisher","first-page":"S440","DOI":"10.1002\/mds.21607","article-title":"The role of iron in restless legs syndrome","volume":"22","author":"Allen","year":"2007","journal-title":"Mov Disord"},{"key":"B118","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1212\/01.wnl.0000325914.50764.a2","article-title":"T2 relaxometry and fMRI of the brain in late-onset restless legs syndrome","volume":"71","author":"Astrakas","year":"2008","journal-title":"Neurology"},{"key":"B119","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.sleep.2007.03.021","article-title":"Cerebral correlates of muscle tone fluctuations in restless legs syndrome: a pilot study with combined functional magnetic resonance imaging and anterior tibial muscle electromyography","volume":"9","author":"Spiegelhalder","year":"2008","journal-title":"Sleep Med"},{"key":"B120","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.sleep.2013.09.030","article-title":"Functional connectivity alternation of the thalamus in restless legs syndrome patients during the asymptomatic period: a resting-state connectivity study using functional magnetic resonance imaging","volume":"15","author":"Ku","year":"2014","journal-title":"Sleep Med"},{"key":"B121","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.sleep.2014.12.029","article-title":"Mapping intrinsic functional brain changes and repetitive transcranial magnetic stimulation neuromodulation in idiopathic restless legs syndrome: a resting-state functional magnetic resonance imaging study","volume":"16","author":"Liu","year":"2015","journal-title":"Sleep Med"},{"key":"B122","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.neulet.2016.02.043","article-title":"Patterns of increased intrinsic functional connectivity in patients with restless legs syndrome are associated with attentional control of sensory inputs","volume":"617","author":"Gorges","year":"2016","journal-title":"Neurosci Lett."},{"key":"B123","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.sleep.2016.05.007","article-title":"Default mode network disturbances in restless legs syndrome\/WilliseEkbom disease","volume":"23","author":"Ku","year":"2016","journal-title":"Sleep Med"},{"key":"B124","doi-asserted-by":"publisher","first-page":"3712","DOI":"10.1093\/brain\/aws266","article-title":"Abnormal medial thalamic metabolism in patients with idiopathic restless legs syndrome","volume":"135","author":"Rizzo","year":"2012","journal-title":"Brain"},{"key":"B125","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1016\/j.sleep.2014.05.019","article-title":"Restless legs syndrome and central nervous system gamma-aminobutyric acid: preliminary associations with periodic limb movements in sleep and restless leg syndrome symptom severity","volume":"15","author":"Winkelman","year":"2014","journal-title":"Sleep Med"},{"key":"B126","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1093\/brain\/awl163","article-title":"Support for dopaminergic hypoactivity in restless legs syndrome: a PET study on D2-receptor binding","volume":"129","author":"Cervenka","year":"2006","journal-title":"Brain"},{"key":"B127","doi-asserted-by":"publisher","first-page":"2625","DOI":"10.1016\/j.neuroimage.2011.08.077","article-title":"MRI estimates of brain iron concentration in normal aging using quantitative susceptibility mapping","volume":"59","author":"Bilgic","year":"2012","journal-title":"Neuroimage"},{"key":"B128","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1212\/WNL.0b013e3181a26b30","article-title":"Brain iron homeostasis and neurodegenerative disease","volume":"72","author":"Benarroch","year":"2009","journal-title":"Neurology"},{"key":"B129","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.mri.2015.02.021","article-title":"Quantifying brain iron deposition in patients with Parkinson's disease using quantitative susceptibility mapping, R2 and R2","volume":"33","author":"Barbosa","year":"2015","journal-title":"Magn Reson Imaging"},{"key":"B130","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1212\/WNL.45.1.182","article-title":"Degeneration of substantia nigra in chronic Parkinson's disease visualized by transcranial color-coded real-time sonography","volume":"45","author":"Becker","year":"1995","journal-title":"Neurology"},{"key":"B131","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1002\/mds.20550","article-title":"In vivo detection of iron and neuromelanin by transcranial sonography: a new approach for early detection of substantia nigra damage","volume":"20","author":"Zecca","year":"2005","journal-title":"Mov Disord."},{"key":"B132","doi-asserted-by":"publisher","first-page":"S677","DOI":"10.1002\/mds.22540","article-title":"Transcranial ultrasound as a risk marker for Parkinson's disease","volume":"24","author":"Berg","year":"2009","journal-title":"Mov Disord."},{"key":"B133","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.spen.2006.08.003","article-title":"Ferroportin in the postnatal rat: implications for axonal transport and neuronal export of iron","volume":"13","author":"Moos","year":"2006","journal-title":"Semin Pediatr Neurol"},{"key":"B134","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1002\/ana.23817","article-title":"Ceruloplasmin dysfunction and therapeutic potential for Parkinson disease","volume":"73","author":"Ayton","year":"2013","journal-title":"Ann Neurol."},{"key":"B135","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1093\/brain\/114.4.1953","article-title":"Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia","volume":"114","author":"Dexter","year":"1991","journal-title":"Brain"},{"key":"B136","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1093\/brain\/aww022","article-title":"Iron and dopamine: a toxic couple","volume":"139","author":"Hare","year":"2016","journal-title":"Brain"},{"key":"B137","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1016\/j.neurobiolaging.2013.09.034","article-title":"Copper pathology in vulnerable brain regions in Parkinson's disease","volume":"35","author":"Davies","year":"2014","journal-title":"Neurobiol Aging"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1111\/jnc.13425","article-title":"Iron neurochemistry in Alzheimer's disease and Parkinson's disease: targets for therapeutics","author":"Belaidi","year":"2015","journal-title":"J Neurochem."},{"key":"B139","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.pneurobio.2015.09.012","article-title":"Interactions of iron, dopamine and neuromelanin pathways in brain aging and Parkinson's disease","volume":"55","author":"Zucca","year":"2015","journal-title":"Prog Neurobiol"},{"key":"B140","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.2174\/092986711795496863","article-title":"Oxidation chemistry of catecholamines and neuronal degeneration: an update","volume":"18","author":"Napolitano","year":"2011","journal-title":"Curr Med Chem."},{"key":"B141","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/978-3-7091-6842-4_7","article-title":"Mechanism of 6-hydroxydopamine neurotoxicity","volume":"50","author":"Glinka","year":"1997","journal-title":"J Neural Transm Suppl"},{"key":"B142","doi-asserted-by":"publisher","first-page":"4177","DOI":"10.1016\/0006-2952(89)90512-1","article-title":"6-Hydroxydopamine releases iron from ferritin and promotes ferritin-dependent lipid peroxidation","volume":"38","author":"Monteiro","year":"1989","journal-title":"Biochem Pharmacol"},{"key":"B143","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1038\/nrneurol.2015.100","article-title":"Is early-life iron exposure critical in neurodegeneration?","volume":"11","author":"Hare","year":"2015","journal-title":"Nat Rev Neurol"},{"key":"B144","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1212\/01.wnl.0000262033.01945.9a","article-title":"Individual dopaminergic neurons show raised iron levels in Parkinson disease","volume":"68","author":"Oakley","year":"2007","journal-title":"Neurology"},{"key":"B145","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.nbd.2011.12.054","article-title":"Iron dysregulation in movement disorders","volume":"46","author":"Dusek","year":"2012","journal-title":"Neurobiol Dis"},{"key":"B146","doi-asserted-by":"publisher","first-page":"14973","DOI":"10.1038\/s41598-017-14721-1","article-title":"Iron deposition in substantia nigra: abnormal iron metabolism, neuroinflammatory mechanism and clinical relevance","volume":"7","author":"Liu","year":"2017","journal-title":"Sci Rep"},{"key":"B147","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1212\/01.WNL.0000138427.83574.A6","article-title":"Restless legs syndrome and pregnancy","volume":"63","author":"Manconi","year":"2004","journal-title":"Neurology"},{"key":"B148","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1002\/ajh.23397","article-title":"The prevalence and impact of restless legs syndrome on patients with iron deficiency anemia","volume":"88","author":"Allen","year":"2013","journal-title":"Am J Hematol"},{"key":"B149","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/S0272-6386(96)90494-1","article-title":"Restless legs syndrome in end-stage renal disease","volume":"28","author":"Winkelman","year":"1996","journal-title":"Am J Kidney Dis"},{"key":"B150","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1212\/01.WNL.0000078887.16593.12","article-title":"Neuropathological examination suggests impaired brain iron acquisition in restless legs syndromev","volume":"61","author":"Connor","year":"2003","journal-title":"Neurology"},{"key":"B151","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1212\/WNL.54.8.1698","article-title":"Abnormalities in CSF concentrations of ferritin and transferrin in restless legs syndromev","volume":"54","author":"Earley","year":"2000","journal-title":"Neurology"},{"key":"B152","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/0091-3057(94)90323-9","article-title":"Altered monamine metabolism in caudate-putamen of iron-deficient ratsv","volume":"48","author":"Beard","year":"1994","journal-title":"Pharmacol Biochem Behav."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fneur.2018.00551\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,5]],"date-time":"2025-07-05T23:51:53Z","timestamp":1751759513000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fneur.2018.00551\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,24]]},"references-count":152,"alternative-id":["10.3389\/fneur.2018.00551"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2018.00551","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,24]]},"article-number":"551"}}